Neubert R, Sauer H, Ambrosius H, Leonhardt P
Allerg Immunol (Leipz). 1980;26(4):361-7.
The number of T lymphocytes in the peripheral blood of normal subjects and patients with bronchial carcinoma was determined by using the E rosette test. In a comparative study we counted the "total" rosette forming cells and the "active" rosette forming cells using a lymphocytes-sheep red cells-ratio (Ly-SRBC-R) of 1:8 and 1:40. The numbers or rosettes in the two test systems are in correlation with the Ly-SRBC-R despite other differences in the techniques. -A significant difference was determined between normal subjects and patients with the "active" rosette test only with a L-SRBC-R of 1:40. By contrast the values with the L-SRBC-R of 1:8 were not very different between the two groups. -Also the number of "total" rosettes was significantly different between blood donors and carcinoma patients, using the L-SRBC-R. 1:40. -These results are not of direct clinical relevance, because the values of normal subjects and carcinoma patients are overlapping.
采用E玫瑰花结试验测定正常受试者和支气管癌患者外周血中T淋巴细胞的数量。在一项对比研究中,我们使用淋巴细胞与绵羊红细胞比例(Ly-SRBC-R)为1:8和1:40的条件,对“总”玫瑰花结形成细胞和“活性”玫瑰花结形成细胞进行计数。尽管技术上存在其他差异,但两个测试系统中玫瑰花结的数量与Ly-SRBC-R相关。——仅在Ly-SRBC-R为1:40时,正常受试者与患者之间的“活性”玫瑰花结试验存在显著差异。相比之下,两组之间Ly-SRBC-R为1:8时的值差异不大。——使用Ly-SRBC-R为1:40时,献血者与癌症患者之间“总”玫瑰花结的数量也存在显著差异。——这些结果与临床无直接相关性,因为正常受试者和癌症患者的值存在重叠。